Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

The 2021 Medical Imaging Report

The 2021 Medical Imaging Report
Insights into the latest trends shaping the medical imaging industry.

COVID-19 resulted in patients holding off most procedures related to oncology, cardiology and neurology. Also, elective procedures came to a halt. Moreover, restructuring of procurement budgets had to be done to address COVID-19 related requirements first. This caused disruptions in trade, supply chain, and manufacturing globally. The medical imaging industry was especially hit hard as this resulted in a delay in procurements of capital-intensive equipment. 

Developed with insights from global research and consulting firm Frost & Sullivan and leading technology research provider Omdia, the 2021 Medical Imaging Report does a deep dive into the impact of COVID-19 on the medical imaging industry, how AI is disrupting the industry, the latest trends shaping it, and the evolution of the discipline from being a diagnostic modality to playing an active role in patient care.

From 2017 to 2019, the imaging industry was growing and adding US$2 billion every year, according to Frost &. Sullivan. However, due to the pandemic in 2020, there was a drop of about 15 per cent in revenue. While recent research from Omdia highlights that as markets stabilise, much of the pent-up demand from delayed equipment purchases in 2020 will be met in 2021 and 2022. Read more of these insights below.

Click to read The 2021 Medical Imaging Report